CompaniesGenus Oncology

Genus Oncology

defunct

About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct

Clinical Trials (3)

Total Trials

3

As Lead Sponsor

1

As Collaborator

2

Total Enrollment

63

By Phase

PHASE1: 2PHASE1/PHASE2: 1

By Status

COMPLETED: 2WITHDRAWN: 1

Clinical Trials Pipeline2 trials

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Phase 1/2

Phase 2/3

N/A

Phase

Status

Role

Condition

2006

2007

2008

2009

2010

2011

2012

2013

2014

Today

Hover over trial bars to see details

Recent Trials

NCT01279603Lead Sponsor

Study of GO-203-2C Given Intravenously in Patients With Advanced Solid Tumors Including Lymphomas

PHASE1Completed

23 participants

Started: Jan 31, 2011 · Completed: May 31, 2013

NCT00559624Collaborator

Safety and Tolerability Open Label Dose Escalation Study of Acadesine in B-CLL Patients

PHASE1/PHASE2Completed

40 participants

Started: Dec 31, 2007 · Completed: Dec 31, 2010

NCT02658396Collaborator

GO-203-2C + Bortezomib For Relapsed Or Refractory MM

PHASE1Withdrawn